{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:50:34Z","timestamp":1784641834567,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ajogmf.2022.100614","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T02:48:42Z","timestamp":1646880522000},"page":"100614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7011-540X","authenticated-orcid":false,"given":"Celeste","family":"Beck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Allshouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Grobman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyagriv","family":"Simhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma M.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan R.","family":"Blue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2022.100614_bib0001","first-page":"276","article-title":"The risks associated with obesity in pregnancy","volume":"115","author":"Stubert","year":"2018","journal-title":"Dtsch arztebl Int"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0002","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/obr.12288","article-title":"Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews","volume":"16","author":"Marchi","year":"2015","journal-title":"Obes Rev"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0003","first-page":"559","article-title":"Obesity in pregnancy: risks and management","volume":"97","author":"Riley","year":"2018","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0004","doi-asserted-by":"crossref","first-page":"j1","DOI":"10.1136\/bmj.j1","article-title":"Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child","volume":"356","author":"Catalano","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0005","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/oby.21165","article-title":"Increased placental nutrient transport in a novel mouse model of maternal obesity with fetal overgrowth","volume":"23","author":"Rosario","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0006","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1530\/REP-16-0495","article-title":"Effects of maternal obesity on placental function and fetal development","volume":"153","author":"Howell","year":"2017","journal-title":"Reproduction"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0007","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.placenta.2014.05.006","article-title":"Maternal prepregnancy obesity is associated with higher risk of placental pathological lesions","volume":"35","author":"Huang","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/micc.12093","article-title":"Regulation of placental angiogenesis","volume":"21","author":"Chen","year":"2014","journal-title":"Microcirculation"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1113\/jphysiol.2005.104430","article-title":"Evidence for altered placental blood flow and vascularity in compromised pregnancies","volume":"572","author":"Reynolds","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0010","first-page":"259","article-title":"Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia","volume":"74","author":"Lecarpentier","year":"2016","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0011","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0012","doi-asserted-by":"crossref","first-page":"19009","DOI":"10.3390\/ijms160819009","article-title":"Angiogenesis-related biomarkers (sFlt-1\/PLGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration","volume":"16","author":"Herraiz","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0013","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0014","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0016","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011-2013","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"539","key":"10.1016\/j.ajogmf.2022.100614_bib0017","first-page":"e1","article-title":"A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b)","volume":"212","author":"Haas","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl2","key":"10.1016\/j.ajogmf.2022.100614_bib0018","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2013the evidence report. National Institutes of Health","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0019","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41366-018-0217-8","article-title":"Impact of obesity on angiogenic and inflammatory markers in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort","volume":"43","author":"J\u00e4\u00e4skel\u00e4inen","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1471-0528.2009.02473.x","article-title":"The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia","volume":"117","author":"Lynch","year":"2010","journal-title":"BJOG"},{"issue":"247","key":"10.1016\/j.ajogmf.2022.100614_bib0021","first-page":"e1","article-title":"The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies","volume":"211","author":"Zera","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0022","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/uog.7548","article-title":"Placental growth factor in the first trimester: relationship with maternal factors and placental Doppler studies","volume":"35","author":"Kasdaglis","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0023","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1515\/jpm-2017-0093","article-title":"Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks\u2019 pregnancy in normotensive women","volume":"45","author":"Wataganara","year":"2017","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0025","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.AOG.0000265804.09161.0d","article-title":"Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth","volume":"109","author":"Smith","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0026","article-title":"First trimester placental growth factor in maternal blood and placenta related disorders","author":"Romero Infante","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0027","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.preghy.2018.06.017","article-title":"Clinical implementation of the sFlt-1\/PlGF ratio to identify preeclampsia and fetal growth restriction: a prospective cohort study","volume":"13","author":"Herraiz","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0028","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/uog.15750","article-title":"Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia","volume":"47","author":"Khalil","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0029","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","article-title":"First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia","volume":"89","author":"Thadhani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0030","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/HJH.0000000000002528","article-title":"Administration of recombinant human placental growth factor decreases blood pressure in obese hypertensive pregnant rats","volume":"38","author":"Palei","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0031","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia","volume":"109","author":"Wikstr\u00f6m","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0032","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.107.087700","article-title":"Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia","volume":"50","author":"Rana","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0033","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1373\/clinchem.2004.036715","article-title":"Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia","volume":"50","author":"Hertig","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0034","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0035","doi-asserted-by":"crossref","first-page":"e32509","DOI":"10.1371\/journal.pone.0032509","article-title":"Serum concentrations of soluble Flt-1 are decreased among women with a viable fetus and no symptoms of miscarriage destined for pregnancy loss","volume":"7","author":"Kaitu'u-Lino","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0036","doi-asserted-by":"crossref","first-page":"E1444","DOI":"10.1210\/jc.2011-0037","article-title":"Soluble FMS-like tyrosine kinase-1 (sFlt-1) and serum placental growth factor (PlGF) as biomarkers for ectopic pregnancy and missed abortion","volume":"96","author":"Daponte","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0037","doi-asserted-by":"crossref","first-page":"e18041","DOI":"10.1371\/journal.pone.0018041","article-title":"Soluble Flt-1 and PlGF: new markers of early pregnancy loss?","volume":"6","author":"Muttukrishna","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0038","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/aogs.13540","article-title":"The role of angiogenic factors in the management of preeclampsia","volume":"98","author":"Flint","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0039","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.111.181735","article-title":"Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy","volume":"59","author":"Perni","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1203\/01.pdr.0000304935.19183.07","article-title":"Regulation of placental growth hormone secretion in a human trophoblast model\u2013the effects of hormones and adipokines","volume":"63","author":"Zeck","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0041","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1933719112452472","article-title":"The influence of overweight and obesity on maternal soluble fms-like tyrosine kinase 1 and its relationship with leptin during pregnancy","volume":"20","author":"Straughen","year":"2013","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0042","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/HYPERTENSIONAHA.111.171322","article-title":"Adipose tissue-derived soluble fms-like tyrosine kinase 1 is an obesity-relevant endogenous paracrine adipokine","volume":"58","author":"Herse","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ajogmf.2022.100614_bib0043","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933322000568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933322000568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:50:21Z","timestamp":1762905021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933322000568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2589933322000568"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100614","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100614"}}